KB Securities tops Korea's ECM rankings The firm brought in proceeds of 142.5 billion won amid an absence of major deals
Translated by Kim So-in 공개 2020-04-02 08:00:01
이 기사는 2020년 04월 02일 08:00 thebell 에 표출된 기사입니다.
South Korea’s equity capital markets (ECM) has been hit hard by the outbreak of the novel coronavirus during the first quarter of 2020. Amid an absence of major deals, KB Securities and Shinhan Investment ranked first and second.KB Securities ranked first in the first three months of 2020, bringing in proceeds of 142.5 billion won, according to the bell’s league table. Shinhan Investment came in second with a total of 124.6 billion won in proceeds. This is the first time that KB Securities and Shinhan Investment ranked first and second, respectively, in the first quarter since data began to be compiled by the bell in 2010.
Last year, NH Investment & Securities topped the ECM rankings while Korea Investment & Securities (KIS) and Samsung Securities ranked second and third, respectively. They all ranked low in the first quarter of 2020, with NH Investment & Securities coming in fourth (77.2 billion won), KIS sitting in eleventh (10.8 billion won) and Samsung Securities coming in ninth (18.3 billion won).
KB Securities led initial public offering (IPO) of PlayD deal, bringing in 31.3 billion won in proceeds. The brokerage firm was a bookrunner of Seoul Viosys (15 billion won) and KB No.20 Special Purpose Acquisition Company (12 billion won). The companies all completed their book building processes in the first two months of 2020. KB Securities was also the joint bookrunner for the rights offer of Hyundai Development Company (HDC) and the 20 billion won bonds with warrants (BW) issue of Seouleaguer.
Shinhan Investment was the joint bookrunner for the IPO of JNTC, the largest IPO deal in the first quarter, collecting 60.5 billion won in proceeds. The brokerage also was the joint bookrunner for the rights offer of HDC, bringing in 64.1 billion won in proceeds. Thanks to the deals, Shinhan Investment ranked first in the IPO market with Eugene Investment & Securities, which was also the joint bookrunner for the IPO of JNTC.
There may be a drastic change in rankings over the course of the year as SK Biopharmaceuticals (SK Biopharm) and Hoban Construction haven’t decided their IPO timelines yet. They are considered landmark deals of 2020 with both IPOs valued at multi-trillion won.
SK Biopharm has passed a preliminary review for listing and is mulling over the timing of the submission of the registration statement. The company is proceeding with its initial plan to have its newly issued shares offered to the public by the end of the first half of 2020 despite the outbreak of the coronavirus.
The company has hired NH Investment & Securities and Citigroup Global Markets as joint bookrunners for its planned one trillion won IPO. NH Investment & Securities may jump to first place as it will be able to bring in 500 billion won in proceeds.
Hoban Construction plans to submit the application for preliminary review for the IPO during the second quarter of 2020. The construction company is reportedly pushing ahead with its initial plan. Some industry insiders say that the company may not be able to submit the application in the first half because stock prices of domestic construction companies have declined due to the government’s real estate regulation measures and the outbreak of the coronavirus.
As of the beginning of 2020, Hoban Construction’s valuation is estimated at three trillion to four trillion won and the company is likely to raise around one trillion won. Mirae Asset Daewoo and KB Securities are acting as joint bookrunners. If the IPO deal completes within this year, the joint bookrunners are expected to be able to climb up the ranks.
(By reporter Lee Kyung-joo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '재무개선' AJ네트웍스, 조달비용 '확' 낮췄다
- '9년만에 엑시트' 한앤코, 한온시스템 거래구조 살펴보니
- 한국타이어앤테크놀로지, 한온시스템 인수한다
- [수술대 오른 커넥트웨이브]2대주주 지분매입 나선 MBK, 주식교환 카드 꺼냈다
- [이사회 모니터]이재용 에이비프로바이오 대표, 바이오·반도체 신사업 '드라이브'
- 와이투솔루션, 주인 바뀌어도 '신약' 중심엔 美 합작사 '룩사'
- 아이티센, 부산디지털자산거래소 본격 출범
- 아이에스시, AI·데이터센터 수주 증가에 '날개'
- [이사회 모니터]서정학 IBK증권 대표, ESG위원회도 참여 '영향력 확대'
- SW클라우드 '10주년' 폴라리스오피스, “초격차 밸류업”